GENE ONLINE|News &
Opinion
Blog

AIDS
HIV Latent Cells Could Lead to Possible Cure
2022-07-28
This One-Time Injection Could Cure AIDS
2022-06-21
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
Gilead, Merck Unite to Contest ViiV’s Cabenuva with Long-Acting HIV Therapy
2021-03-16
Gilead Reports FDA-Approved HIV Therapy Demonstrates Long-Term Efficacy
2021-03-11
Gilead Aspires to Prolong Leadership in HIV Market, Launches Therapeutic Vaccine Quest with Gritstone
2021-02-03
Game-Changing Antiretroviral Regimen from ViiV Receives FDA Approval
2021-01-22
ViiV Healthcare’s Two Drug Regimen Shows Promising Results in HIV-1 Patients
2020-10-06
Merck Reports Higher Efficacy for Islatravir Doravirine Combo in Adults with HIV-1 Infection
2020-07-09
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
The Scientists Strongly Condemned for the First Gene Editing Baby’s Birth in China
2018-11-27
US FDA Allows Phase II Clinical Trials for China’s anti-HIV Two-Drug Combo Therapy
2018-09-07
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top